About this medicine
- Approved name
- Substances related to nicotinic acid
- International non-proprietary name (INN) or common name
- acipimox
- Associated names
- Olbetam
- Class
- Lipid-lowering agents
About this procedure
- Current status
- European Commission final decision
- Reference number
- EMEA/H/A-31/1366
- Type
- Article 31 referrals
This type of referral is triggered when the interest of the Union is involved, following concerns relating to the quality, safety or efficacy of a medicine or a class of medicines.
- Authorisation model
- Nationally authorised product(s)
- Decision making model
- PRAC-CMDh
Key dates and outcomes
- Procedure start date
- 07/03/2013
- PRAC recommendation date
- 07/11/2013
- CMDh position date
- 18/12/2013
- EC decision date
- 20/02/2014
- Outcome
- Variation